Carmen Belli

2.4k total citations · 1 hit paper
60 papers, 1.7k citations indexed

About

Carmen Belli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Carmen Belli has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Carmen Belli's work include Pancreatic and Hepatic Oncology Research (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Cancer Genomics and Diagnostics (10 papers). Carmen Belli is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Cancer Genomics and Diagnostics (10 papers). Carmen Belli collaborates with scholars based in Italy, United States and Switzerland. Carmen Belli's co-authors include Giuseppe Curigliano, Bruno A. Duso, Dario Trapani, Paolo D’Amico, Giulia Viale, Paolo Della Vigna, Franco Orsi, Michele Reni, Stefano Cereda and Santosh Anand and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Carmen Belli

57 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the microenvironment in solid tumors

2018 385 citations Carmen Belli, Dario Trapani et al. Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmen Belli Italy	20	1.0k	550	517	401	282	60	1.7k
Pol Specenier Belgium	21	1.1k 1.1×	624 1.1×	542 1.0×	261 0.7×	287 1.0×	84	1.9k
Valentina Gambardella Spain	18	755 0.8×	474 0.9×	471 0.9×	485 1.2×	207 0.7×	85	1.5k
Haijun Deng China	25	994 1.0×	730 1.3×	659 1.3×	611 1.5×	491 1.7×	72	2.1k
Gayle Jameson United States	19	944 0.9×	546 1.0×	399 0.8×	556 1.4×	160 0.6×	76	1.6k
Roberto Pazo-Cid Spain	17	801 0.8×	331 0.6×	553 1.1×	335 0.8×	295 1.0×	69	1.4k
Puay Hoon Tan Singapore	18	484 0.5×	597 1.1×	461 0.9×	361 0.9×	261 0.9×	41	1.4k
Antonella Argentiero Italy	23	794 0.8×	596 1.1×	326 0.6×	427 1.1×	140 0.5×	48	1.6k
Marine Gilabert France	22	910 0.9×	395 0.7×	422 0.8×	399 1.0×	276 1.0×	73	1.8k
Lorena Incorvaia Italy	24	910 0.9×	602 1.1×	675 1.3×	481 1.2×	225 0.8×	113	1.9k

Countries citing papers authored by Carmen Belli

Since Specialization

Citations

This map shows the geographic impact of Carmen Belli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Belli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Belli more than expected).

Fields of papers citing papers by Carmen Belli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Belli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Belli. The network helps show where Carmen Belli may publish in the future.

Co-authorship network of co-authors of Carmen Belli

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Belli. A scholar is included among the top collaborators of Carmen Belli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Belli. Carmen Belli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belli, Carmen, Luca Boscolo Bielo, Matteo Repetto, et al.. (2024). Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers. The Oncologist. 29(8). 707–715. 2 indexed citations

Bielo, Luca Boscolo, Matteo Repetto, Edoardo Crimini, et al.. (2024). Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. The Oncologist. 29(7). 560–565. 2 indexed citations

Valenza, Carmine, Dario Trapani, Edoardo Crimini, et al.. (2024). Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study. ESMO Open. 9(8). 103662–103662.

Dummer, Reinhard, Jacopo Pigozzo, Paolo A. Ascierto, et al.. (2024). 1083P KEYMAKER 02B: A randomized trial of pembrolizumab (pembro) alone or with investigational agents as first-line treatment for advanced melanoma. Annals of Oncology. 35. S717–S718. 1 indexed citations

Mach, Nicolas, Carmen Belli, Eduardo Fernández, et al.. (2023). 1037P Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors. Annals of Oncology. 34. S629–S630. 2 indexed citations

Bielo, Luca Boscolo, Dario Trapani, Matteo Repetto, et al.. (2023). Variant allele frequency: a decision-making tool in precision oncology?. Trends in cancer. 9(12). 1058–1068. 35 indexed citations

Repetto, Matteo, Edoardo Crimini, Carmen Belli, et al.. (2023). A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing data. European Journal of Cancer. 190. 112958–112958.

Corti, Francesca, Sara Lonardi, Rossana Intini, et al.. (2021). The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. European Journal of Cancer. 150. 155–167. 78 indexed citations

Aliaga, Pamela Trillo, Dario Trapani, José Luís Sandoval, et al.. (2021). Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers. 13(22). 5829–5829. 10 indexed citations

10.

Mazzarella, Luca, Silvia Giugliano, Paolo D’Amico, et al.. (2020). Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity. European Journal of Cancer. 141. 218–224. 14 indexed citations

11.

Tarantino, Paolo, Antonio Marra, Sara Gandini, et al.. (2020). Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents. European Journal of Cancer. 139. 92–98. 15 indexed citations

12.

Mazzarella, Luca, Bruno A. Duso, Dario Trapani, et al.. (2019). The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review. European Journal of Cancer. 117. 14–31. 80 indexed citations

13.

Belli, Carmen, Bruno A. Duso, Emanuela Ferraro, & Giuseppe Curigliano. (2019). Homologous recombination deficiency in triple negative breast cancer. The Breast. 45. 15–21. 59 indexed citations

14.

Belli, Carmen, Massimo Zuin, Luca Mazzarella, et al.. (2018). Liver toxicity in the era of immune checkpoint inhibitors: A practical approach. Critical Reviews in Oncology/Hematology. 132. 125–129. 21 indexed citations

15.

Duso, Bruno A., Dario Trapani, Giulia Viale, et al.. (2018). Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer. Expert Opinion on Pharmacotherapy. 19(3). 299–305. 4 indexed citations

16.

Reni, Michele, Erica Dugnani, Stefano Cereda, et al.. (2015). (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial. Clinical Cancer Research. 22(5). 1076–1085. 140 indexed citations

17.

Cereda, Stefano, Carmen Belli, Alessia Rognone, Elena Mazza, & Michele Reni. (2013). Second-line therapy in advanced biliary tract cancer: What should be the standard?. Critical Reviews in Oncology/Hematology. 88(2). 368–374. 16 indexed citations

18.

Belli, Carmen, Stefano Cereda, Santosh Anand, & Michele Reni. (2012). Neoadjuvant therapy in resectable pancreatic cancer: A critical review. Cancer Treatment Reviews. 39(5). 518–524. 36 indexed citations

19.

Belli, Carmen, Santosh Anand, Gianfranco Tassi, Dean A. Fennell, & Luciano Mutti. (2010). Translational therapies for malignant pleural mesothelioma. Expert Review of Respiratory Medicine. 4(2). 249–260. 4 indexed citations

20.

Iovino, Francesco, Francesca Ferraraccio, Michele Orditura, et al.. (2008). Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer. Cancer Investigation. 26(3). 250–255. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact